stay up to date on this topic
a new study has found that cancer patients are more likely to develop diabetes, and that those who are subsequently diagnosed with the metabolic disease do not live as long as other cancer survivors.
the study,
which was published in the journal diabetes care, found that certain types of cancer were more likely to increase the risk of diabetes than others. as this work is the first of its kind to establish such an association, the team cautioned that further study is required to confirm its findings.
“our study demonstrates that there is an elevated risk of developing diabetes if a person is affected by lung, pancreatic, breast, brain, urinary tract or uterine cancers,”
said lykke sylow, an associate professor in the department of nutrition, exercise and sports at the university of copenhagen.
although the team of researchers, who relied on a dataset containing 112 million blood samples from 1.3 million danes — more than 50,000 of whom developed cancer — could not explain the association, they presented a few possibilities. “various cancer therapies may contribute to an increased risk,” sylow said.
“the cancer itself can affect the rest of the body. we know that cancer cells are able to secrete substances that can affect organs and possibly contribute to an increased incidence of diabetes. this has been suggested in animal studies.”
the study also showed that cancer survivors who developed diabetes generally died sooner than those that did not, experiencing an excess mortality of 21 per cent. the research, which combined all cancers and did not analyze risk by specific cancer, suggests a simple measure that may improve the prognosis and quality of life of patients.
“it might be relevant to consider diabetes screenings in relation to those cancers where we found an elevated risk of the disease,” said christoffer johansen, a professor at the national centre for cancer survivorship and general late effects (castle) at rigshospitalet. “that is to say, for patients with lung cancer, breast cancer, brain cancer, uterine cancer and urinary tract cancers. we have outstanding opportunities to treat diabetes and early intervention could have an impact on certain cancer patients.”